Purpose | Board Meetings Date | Announcement Date |
---|---|---|
Board Meeting | 7 Feb 2025 | 29 Jan 2025 |
SICAGEN INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 inter alia to consider and approve the Un-audited Financial Results (both Standalone & Consolidated) of the Company for the Quarter & Nine months ended 31st December 2024. Submission of Unaudited Financial Results (Standalone & Consolidated) of the Company for the Quarter & nine months ended 31st December, 2024. The Board of Directors at its meeting held on 07.02.2025 i.e. today has inter-alia considered and approved the Unaudited Financial Results (Standalone & Consolidated) together with the Limited Review Reports of the Auditors for the Quarter & Nine months ended 31st December, 2024 (As Per Bse Announcement Dated on 07.02.2025) | ||
Board Meeting | 5 Nov 2024 | 28 Oct 2024 |
SICAGEN INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2024 inter alia to consider and approve the Un-audited Financial Results (both Standalone & Consolidated) of the Company for the Quarter & half year ended 30th September 2024. The Board of Directors of the Company at its meeting held today has, inter alia, considered and approved the Un-audited Standalone and Consolidated Financial Results of the Company along with the Limited Review Reports of auditors for the quarter and half year ended 30th Sept 2024. The copies of the aforesaid Un-audited Financial Results are attached. Out come of Board Meeting dated 05.11.2024 is attached (As per BSE Announcement Dated on 05/11/2024) | ||
Board Meeting | 7 Aug 2024 | 30 Jul 2024 |
SICAGEN INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2024 inter alia to consider and approve the Un-audited Financial Results (both Standalone & Consolidated) of the Company for the Quarter ended 30th June 2024. The Board of Directors at its meeting held on today i.e. 07.08.2024 has inter-alia considered and approved the Unaudited Financial Results for the quarter ended 30th June, 2024. Outcome of the Board meeting dated 07.08.2024. (As Per BSE Announcement dated on 07.08.2024) | ||
Board Meeting | 15 May 2024 | 30 Apr 2024 |
Final Dividend & Audited Results In the meeting of Board of Directors of the Company held on 15.05.2024 i.e. today, the Board has inter alia considered and approved the Audited Financial Results (both Standalone & Consolidated) of the Company for the Quarter and year ended 31st March, 2024 together with the Auditors Report thereon. The Board has also recommended 6% Equity Dividend (60 paise per share) on Equity Capital of the Company for the Financial Year 2023-24. (As Per BSE Announcement Dated on 15.05.2024) |
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.